Alpha Teknova, Inc.

    Jurisdiction
    United States
    ISIN
    US02080L1026 (TKNO)
    Sectors
    1. Healthcare
    2. Drug Manufacturers - Specialty & Generic

    Scores

    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    7 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    2 / 7

    Profile

    Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €33.41M
    Gross margin
    23.7%
    EBIT
    -€18.38M
    EBIT margin
    -55.0%
    Net income
    -€18.46M
    Net margin
    -55.2%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €39.81M +19.1% -€14.77M -20.0%
    €45.75M +14.9% -€11.63M -21.3%
    €58.73M +28.4% -€7.96M -31.5%

    Dividends

    No dividend payouts

    Earnings Calls

    Latest earnings call: May 13, 2024

    Investor transactions

    Name Shares Value Last change Change type
    Peter Brown 48K $247.56K -19K Sell

    Add to watchlist

    Notifications